{
    "SPADE_N_00079": {
        "Clinical Information": [],
        "Patent Information": [
            {
                "Patent No": "US 2023/0416797 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2023-12-28",
                "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1",
                "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE",
                "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."
            },
            {
                "Patent No": "US 2023/0416797 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2023-12-28",
                "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1",
                "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE",
                "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."
            },
            {
                "Patent No": "US 2023/0416797 A1",
                "Patent Link": "http://www.lens.org/lens/patent/US_2023_0416797_A1",
                "Patent Type": "Patent Application",
                "Publication Date": "2023-12-28",
                "Family Info": "JP2023548477A,EP4243844A1,CN116685204A,WO2022104321A1",
                "Patent Title": "MODULATING ANTIMICROBIAL PEPTIDE HALF-LIFE",
                "Abstract": "Methods of modulating the half-life of an antimicrobial peptide are described. The method may include administering an antimicrobial peptide to an environment where the antimicrobial peptide remains active until a specified endpoint, and on or after the specified endpoint, digesting the antimicrobial peptide with a protease to thereby inactivate the antimicrobial peptide and modulate its half-life. Compositions and kits for modulating the half-life of an antimicrobial peptide are also described."
            }
        ],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_00079",
            "Peptide Name": "Bacteriocin SRCAM 37",
            "Source": "Paenibacillus polymyxa (Bacillus polymyxa) (Gram-positive bacteria)",
            "Family": "Belongs to the class IIa bacteriocin",
            "Gene": "Not found",
            "Sequence": "FVYGNGVTSILVQAQFLVNGQRRFFYTPDK",
            "Sequence Length": 30,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/P86395"
            ],
            "Protein Existence": "Protein level",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+"
            ],
            "Target Organism": "Gram-positive bacteria:Clostridium jejuni.",
            "Hemolytic Activity": "No hemolysis information or data found in the reference(s) presented in this entry",
            "Cytotoxicity": "Not included yet",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not included yet",
            "N-terminal Modification": "Not included yet",
            "C-terminal Modification": "Not included yet",
            "Stereochemistry": "Not included yet",
            "Structure Description": "Not found",
            "Formula": "C162H242N42O43",
            "Mass": 3465.91,
            "PI": 9.7,
            "Net Charge": 2,
            "Hydrophobicity": 0.01,
            "Half Life": "Mammalian:1.1 hourYeast:3 minE.coli:2 min",
            "Function": "Bacteriocin with antibacterial activity.",
            "Biophysicochemical properties": "pH dependence (Stable from pH 3.0-9.0, inactivated at pH 10.0); Temperature dependence (Thermostable, activity is retained after incubation at 100 degrees Celsius for 15 minutes).",
            "Miscellaneous": "Antimicrobial activity is lost upon treatment with beta-chymotrypsin, proteinase K and papain, but not when treated with lysozyme or lipase.",
            "Literature": [
                {
                    "Title": "Isolation of Bacillus circulans and Paenibacillus polymyxa strains inhibitory to Campylobacter jejuni and characterization of associated bacteriocins.",
                    "Pubmed ID": "15690798",
                    "Reference": "J Food Prot. 2005 Jan;68(1)11-17.",
                    "Author": "Svetoch EA, Stern NJ, Eruslanov BV, Kovalev YN, Volodina LI, Perelygin VV, Mitsevich EV, Mitsevich IP, Pokhilenko VD, Borzenkov VN, Levchuk VP, Svetoch OE, Kudriavtseva TY.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=15690798"
                },
                {
                    "Title": "Bacteriocins reduce Campylobacter colonization and alter gut morphology in turkey poults.",
                    "Pubmed ID": "16977842",
                    "Reference": "Poult Sci. 2006 Sep;85(9)1570-1575.",
                    "Author": "Cole K, Farnell MB, Donoghue AM, Stern NJ, Svetoch EA, Eruslanov BN, Volodina LI, Kovalev YN, Perelygin VV, Mitsevich EV, Mitsevich IP, Levchuk VP, Pokhilenko VD, Borzenkov VN, Svetoch OE, Kudryavtseva TY, Reyes-Herrera I, Blore PJ, Solis de los Santos F, Donoghue DJ.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=16977842"
                }
            ],
            "Frequent Amino Acids": "FVG",
            "Absent Amino Acids": "CEHMOUW",
            "Basic Residues": 3,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 15,
            "Polar Residues": 18,
            "Positive Residues": 3,
            "Negative Residues": 1,
            "Similar Sequences": []
        }
    }
}